Sivik Global Healthcare’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-170,000
| Closed | -$3.06M | – | 45 |
|
2024
Q3 | $3.06M | Sell |
170,000
-30,000
| -15% | -$541K | 1.3% | 31 |
|
2024
Q2 | $3.25M | Buy |
200,000
+25,000
| +14% | +$406K | 1.17% | 31 |
|
2024
Q1 | $2.47M | Buy |
+175,000
| New | +$2.47M | 0.58% | 43 |
|
2020
Q3 | – | Sell |
-275,000
| Closed | -$3.39M | – | 57 |
|
2020
Q2 | $3.39M | Buy |
+275,000
| New | +$3.39M | 1.12% | 40 |
|
2019
Q2 | – | Sell |
-215,000
| Closed | -$3.37M | – | 68 |
|
2019
Q1 | $3.37M | Buy |
215,000
+30,000
| +16% | +$470K | 1.24% | 39 |
|
2018
Q4 | $2.85M | Sell |
185,000
-15,000
| -8% | -$231K | 1.54% | 31 |
|
2018
Q3 | $4.31M | Sell |
200,000
-85,000
| -30% | -$1.83M | 1.54% | 32 |
|
2018
Q2 | $6.93M | Sell |
285,000
-70,000
| -20% | -$1.7M | 2.67% | 8 |
|
2018
Q1 | $6.07M | Buy |
355,000
+80,000
| +29% | +$1.37M | 2.83% | 10 |
|
2017
Q4 | $5.21M | Buy |
275,000
+175,000
| +175% | +$3.32M | 1.93% | 20 |
|
2017
Q3 | $1.76M | Buy |
+100,000
| New | +$1.76M | 0.6% | 61 |
|
2017
Q2 | – | Sell |
-50,000
| Closed | -$1.61M | – | 72 |
|
2017
Q1 | $1.61M | Buy |
+50,000
| New | +$1.61M | 0.75% | 49 |
|
2016
Q4 | – | Hold |
0
| – | – | – | 65 |
|
2016
Q3 | – | Hold |
0
| – | – | – | 60 |
|
2016
Q2 | – | Sell |
-46,000
| Closed | -$2.46M | – | 64 |
|
2016
Q1 | $2.46M | Sell |
46,000
-45,000
| -49% | -$2.41M | 1.09% | 38 |
|
2015
Q4 | $5.97M | Buy |
91,000
+11,600
| +15% | +$761K | 2.84% | 5 |
|
2015
Q3 | $4.48M | Sell |
79,400
-10,000
| -11% | -$565K | 2.17% | 19 |
|
2015
Q2 | $5.28M | Buy |
89,400
+9,400
| +12% | +$556K | 1.83% | 18 |
|
2015
Q1 | $4.98M | Buy |
80,000
+20,700
| +35% | +$1.29M | 1.7% | 21 |
|
2014
Q4 | $3.41M | Buy |
59,300
+4,300
| +8% | +$247K | 1.38% | 32 |
|
2014
Q3 | $2.96M | Hold |
55,000
| – | – | 1.34% | 37 |
|
2014
Q2 | $2.88M | Sell |
55,000
-14,350
| -21% | -$752K | 1.46% | 30 |
|
2014
Q1 | $3.66M | Buy |
69,350
+9,350
| +16% | +$494K | 2.29% | 8 |
|
2013
Q4 | $2.41M | Buy |
+60,000
| New | +$2.41M | 1.71% | 30 |
|